Company Overview and News
VANCOUVER, British Columbia, April 02, 2018 (GLOBE NEWSWIRE) -- Midas Gold Corp. (TSX:MAX) (OTCQX:MDRPF) today announced that the United States Forest Service (“USFS”) has updated the anticipated permitting schedule for Midas Gold Idaho’s Stibnite Gold Project (“Project”), which is located in Valley County, 39 miles east of McCall and 14 miles from Yellow Pine, Idaho. The USFS, in cooperation with the six other federal, state and local agencies responsible for the permitting schedule, anticipates issuing a draft Environmental Impact Statement (“EIS”) for public comment in November 2018, with a Final EIS and Draft Record of Decision (“ROD”) by July 2019.
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Midas Gold Corp. (TSX:MAX) (OTCQX:MDRPF) today reported that it has appointed Javier Shiffrin, Senior Vice President, Paulson & Co. Inc., to its board of directors following the resignation of Victor Flores. Mr. Schiffrin was nominated by Paulson & Co. under the investor rights agreement entered into with Midas Gold in relation to the March 2016 financing that was backstopped by Paulson & Co.
Good day, ladies and gentlemen. Welcome to Vista Gold’s 2017 Financial Results and 2018 Corporate Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. Today is Friday, March 9, 2017. It is now my pleasure to introduce Vista’s President and CEO and your host, Mr. Fred Earnest. Please go ahead, Mr. Earnest.
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
LONDON, UK / ACCESSWIRE / December 29, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Metals & Mining industry: Rubicon Minerals, Midas Gold, Canadian Zinc, and Endeavour Mining. Access our complimentary up-to-the-minute research reports by becoming an online member now: www.active-investors.com/registration-sg.
VANCOUVER, BC--(Marketwired - September 18, 2017) - Midas Gold Corp. (TSX: MAX) (OTCQX: MDRPF) today announced that seven federal, state and local agencies have entered into an agreement outlining their commitment to work together and coordinate their efforts to permit Midas Gold Idaho's Stibnite Gold Project ("Project"), which is located in Valley County, 39 miles east of McCall and just outside of Yellow Pine, Idaho.
VANCOUVER, BC--(Marketwired - September 13, 2017) - Midas Gold Corp. (TSX: MAX) (OTCQX: MDRPF) today announced that management will be attending and presenting at two upcoming investment conferences in Colorado, USA.
Good day, ladies and gentlemen. Welcome to today’s Vista Gold Second Quarter 2017 Financial Results and Quarterly Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today and it is Wednesday, August 9, 2017. It is now my pleasure to introduce Vista’s President and CEO and your host, Mr. Fred Earnest. Please go ahead.
DENVER, Aug. 7, 2017 /PRNewswire/ -- Vista Gold Corp. (the "Company," "we" or "our") (NYSE American: VGZ) (TSX: VGZ) today announced its unaudited financial results for the second quarter ended June 30, 2017. Management's quarterly conference call to discuss these results is scheduled for 2:30 p.m. MDT on August 9, 2017. The Company's unaudited financial statements, Management's Discussion and Analysis together with other important disclosures can be found in the Company's Quarterly Report on Form 10-Q, filed on August 4, 2017 with the U.
LONDON, UK / ACCESSWIRE / July 6, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Metals & Mining industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Midas Gold, Canadian Zinc, Endeavour Mining, and TriMetals Mining.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 15, 2017) - Desert Star Resources Ltd. (TSX VENTURE:DSR) ("Desert Star" or the "Company") is pleased to announce it has signed a definitive agreement dated June 15, 2017 (the "Agreement") with Capstone Mining Corp. ("Capstone") to acquire 100% of the Kutcho high grade copper-zinc-gold-silver project ("Kutcho"). The consideration for the acquisition of Capstone's wholly-owned subsidiary Kutcho Copper Corp.
VANCOUVER, BC--(Marketwired - June 05, 2017) - Midas Gold Corp. (TSX: MAX) (OTCQX: MDRPF) today announced that the Notice of Intent ("NOI") to prepare an Environmental Impact Statement ("EIS") on the proposed Stibnite Gold Project's Plan of Restoration and Operations ("PRO") was published in the Federal Register on Monday, June 5, 2017 by the United States Forest Service ("USFS"). The NOI marks the opening of the 45-day scoping period, which includes three public meetings and opportunity for the public to provide written comments to the USFS, the lead agency on the Stibnite Gold Project.
VANCOUVER, BC--(Marketwired - May 11, 2017) - Midas Gold Corp. (TSX: MAX) (OTCQX: MDRPF) ("Midas Gold" or the "Company") today announced the results of its annual general meeting (the "AGM"), which was held in Vancouver on May 11, 2017. Following the meeting, Stephen Quin, President and CEO, provided those present with an overview of the Company's progress over the past year and its plans going forward.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...